Nicole Kar, Bella Spring & Emma Cochrane (Linklaters)
The global pandemic has suddenly – and rightly – dominated people’s attention. But there is another more significant global emergency raging in our midst: climate change. Over the last year, we have seen a marked increase in the number of clients talking to us about competition law and sustainability. From a desire to co-operate to achieve green objectives, to environmental factors that are driving a deal, these issues are coming up again and again.
As advisors, bound by confidentiality obligations, we can’t talk about the cases that we advise on in specific terms or tell people about the cases where we see environmental initiatives fail to even get off the ground because of concerns about potential competition risk. But we think it is really important to highlight how these issues are coming to the forefront and to offer solutions.
We have commissioned some research looking at what is driving companies’ decision-making on sustainability and competition law. You can see our summary results here. Spoiler alert: competition law is a genuine barrier to companies co-operating on environmental grounds and many companies believe, like us, that competition agencies should act…
Featured News
Federal Judge Signals Revisions Likely in DOJ Case Targeting Live Nation Monopoly
Jan 22, 2025 by
CPI
American Airlines and JetBlue Agree to $2 Million Legal Fee Settlement with U.S. States
Jan 22, 2025 by
CPI
Federal Judge Dismisses Class Action Alleging Inflated Yacht Commission Fees
Jan 22, 2025 by
CPI
Doug Gurr Appointed Interim Chairman of UK’s Competition Authority
Jan 22, 2025 by
CPI
LinkedIn Faces Lawsuit Over Alleged Misuse of Customer Data for AI Training
Jan 22, 2025 by
Amanda Adams
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan